首页> Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology> Benefit from the inclusion of radiation therapy in the treatment of patients with stage III classical Hodgkin lymphoma: A propensity matched analysis of the Surveillance, Epidemiology, and End Results database.

Benefit from the inclusion of radiation therapy in the treatment of patients with stage III classical Hodgkin lymphoma: A propensity matched analysis of the Surveillance, Epidemiology, and End Results database.

导出原文传递

翻译打印收藏纠错

第一作者： James E,Bates

第一单位： Department of Radiation Oncology, University of Florida, Gainesville, USA.

作者： James E,Bates ^[1] ; Sughosh,Dhakal ^[2] ; Ali,Mazloom ^[3] ; Carla,Casulo ^[4] ; Louis S,Constine ^[5]

作者单位： Department of Radiation Oncology, University of Florida, Gainesville, USA. ^[1] Department of Radiation Oncology, Wilmot Cancer Institute, University of Rochester Medical Center, USA. ^[2] Tacoma Valley Radiation Oncology Center, USA. ^[3] Department of Medicine, Division of Medical Oncology, Wilmot Cancer Institute, University of Rochester Medical Center, USA. ^[4] Department of Radiation Oncology, Wilmot Cancer Institute, University of Rochester Medical Center, USA. Electronic address: louis_constine@urmc.rochester.edu. ^[5]

关键词 Classical Hodgkin lymphoma Radiotherapy SEER